Related Experiment Videos
Immuno-enhancing effects of ricin
1Disease Assessment Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011.
Immunopharmacology and Immunotoxicology
|January 1, 1991
Summary
Ricin at low doses enhances interleukin-1 production by human immune cells. However, higher ricin concentrations suppress immune cell activity and interleukin-1 production, revealing a dose-dependent effect on immune responses.
Area of Science:
- Immunology
- Toxicology
Background:
- Ricin is a potent toxin derived from castor beans.
- Its effects on human immune cells, particularly peripheral blood mononuclear cells (PBMC), require detailed investigation.
Purpose of the Study:
- To investigate the in vitro effects of ricin on human peripheral blood mononuclear cells (PBMC).
- To determine ricin's impact on cytokine production and cellular proliferation.
Main Methods:
- Human peripheral blood mononuclear cells (PBMC) were cultured in vitro.
- Cells were exposed to varying concentrations of ricin.
- Interleukin-1 (IL-1) production and mitogen-induced proliferation were measured.
Main Results:
- Low ricin concentrations (10^-3 to 10^-4 µg/ml) potentiated lipopolysaccharide-induced IL-1 production.
- Ricin did not exhibit mitogenic or co-mitogenic effects at concentrations below 10^-4 µg/ml.
- Higher ricin concentrations (>10^-3 µg/ml) inhibited IL-1 production and mitogen-driven PBMC proliferation.
Conclusions:
- Ricin exhibits dose-dependent immunomodulatory effects on human PBMCs.
- Low concentrations of ricin can enhance certain immune responses, while higher concentrations are immunosuppressive.